177 related articles for article (PubMed ID: 25868140)
41. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.
Vriend HJ; Bogaards JA; van Bergen JE; Brink AA; van den Broek IV; Hoebe CJ; King AJ; van der Sande MA; Wolffs PF; de Melker HE;
Cancer Med; 2015 Oct; 4(10):1589-98. PubMed ID: 26194784
[TBL] [Abstract][Full Text] [Related]
42. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
43. The natural history of type-specific human papillomavirus infections in female university students.
Richardson H; Kelsall G; Tellier P; Voyer H; Abrahamowicz M; Ferenczy A; Coutlée F; Franco EL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):485-90. PubMed ID: 12814991
[TBL] [Abstract][Full Text] [Related]
44. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of human papillomavirus genotypes among women in Hunan province, China.
Li H; Zhang J; Chen Z; Zhou B; Tan Y
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):202-5. PubMed ID: 23787251
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.
Dunne EF; Klein NP; Naleway AL; Baxter R; Weinmann S; Riedlinger K; Fetterman B; Steinau M; Scarbrough MZ; Gee J; Markowitz LE; Unger ER
Cancer Causes Control; 2013 Feb; 24(2):403-7. PubMed ID: 23292130
[TBL] [Abstract][Full Text] [Related]
48. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
49. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Hernandez-Avila M; Brown DR; Elbasha E; Muñoz N; Paavonen J; Haupt RM;
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):287-96. PubMed ID: 21300618
[TBL] [Abstract][Full Text] [Related]
50. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
51. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.
Syrjänen S; Shabalova I; Petrovichev N; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Juschenko A; Tosi P; Syrjänen K;
Int J STD AIDS; 2005 Mar; 16(3):217-23. PubMed ID: 15835076
[TBL] [Abstract][Full Text] [Related]
52. The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.
Keane A; Ng CW; Simms KT; Nguyen D; Woo YL; Saville M; Canfell K
Int J Cancer; 2021 Dec; 149(12):1997-2009. PubMed ID: 34363620
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
Six L; Leodolter S; Sings HL; Barr E; Haupt R; Joura EA
Wien Klin Wochenschr; 2008; 120(21-22):666-71. PubMed ID: 19116707
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
55. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
Syrjänen K
Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus and cervical neoplasia among female sex workers in Madagascar.
Smith JS; Van Damme K; Randrianjafisamindrakotroka N; Ting J; Rabozakandraina T; Randrianasolo BS; Raharinivo M; Zanasaotra S; Hobbs M; Rinas A; Cohen M; Gravitt P; Behets F
Int J Gynecol Cancer; 2010 Dec; 20(9):1593-6. PubMed ID: 21370602
[TBL] [Abstract][Full Text] [Related]
58. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
[TBL] [Abstract][Full Text] [Related]
59. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.
Sargent A; Bailey A; Almonte M; Turner A; Thomson C; Peto J; Desai M; Mather J; Moss S; Roberts C; Kitchener HC;
Br J Cancer; 2008 May; 98(10):1704-9. PubMed ID: 18392052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
